DoubleLine Securitized Credit ETF (DSCO) Covered Calls

DoubleLine Securitized Credit ETF covered calls Discovery Laboratories, Inc. is engaged in the development of Surfactant Replacement Therapies (SRT) to treat respiratory disorders and diseases for which there frequently are few or no approved therapies.

There are no covered calls available for DoubleLine Securitized Credit ETF.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Discovery Laboratories, Inc. is engaged in the manufacture and development of products for infants and respiratory diseases. It focuses on producing surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded on November 6, 1992 and is headquartered in Warrington, PA.